CHROMATIN: GENTING UNIT IN JV FOR BIOTECH PROJECT
TheStar Online
PETALING JAYA: ACGT Sdn Bhd and Chromatin Inc have signed a memorandum of understanding (MOU) to pursue a long term research agreement to develop mini-chromosome technology.
The companies signed the MOU in conjunction with the Bio International Convention in Chicago.
ACGT, a wholly-owned subsidiary of Genting Plantations Bhd, is a centre of excellence in genomic science focused on the application of genome technology to improve crop plants for sustainable food and fuel.
Chromatin is a biotech company developing and marketing innovative technologies and products that benefit the agricultural, energy, chemical, nutritional and pharmaceutical sectors.
“This collaborative relationship with ACGT strengthens Chromatin’s business links with Malaysia, which began in late 2008 with an investment from The Malaysian Life Sciences Capital Fund,” said Chromatin chief executive officer (CEO) Daphne Preuss said in a statement yesterday.
“Chromatin looks forward to a mutually beneficial partnership with ACGT to develop biotech solutions which can increase productivity and enhance value creation for multiple crops,” she added.
ACGT CEO Derrik Khoo Sin Huat said the company’s partnership with Chromatin built on its success in establishing strategic business relationships with innovative technology companies.
“By working together, we can leverage the strength of both companies to responsibly produce sustainable agricultural products,” he said.
Formerly known as Asiatic Centre for Genome Technology Sdn Bhd, ACGT is a BioNexus status company.